Rogco, LP Abb Vie Inc. Transaction History

Rogco, LP

$255 Billion
Q3 2024

A detailed history of Rogco, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Rogco, LP holds 8,132 shares of ABBV stock, worth $1.44 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

8,132

Previous 9,061 10.25%

Holding current value

$1.44 Million

Previous $1.55 Billion 3.33%

% of portfolio

0.63%

Previous 0.63%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $152,207 - $185,177	-929 Reduced 10.25%	8,132 $1.61 Billion
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $22,444 - $26,210	145 Added 1.63%	9,061 $1.55 Billion
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $1.02 Million - $1.16 Million	-6,382 Reduced 41.72%	8,916 $1.62 Billion
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $341,385 - $384,480	2,481 Added 19.36%	15,298 $2.37 Billion
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.71 Million - $1.98 Million	12,817 New	12,817 $1.91 Billion

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rogco, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rogco, LP with notifications on news.

Account